Inhaled Β-Agonist Does Not Modify Sympathetic Activity in Patients With COPD

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-015-0054-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EXPRESS: Bisoprolol Therapy Does Not Reduce Right Ventricular Sympathetic Activity in Pulmonary Arterial Hypertension Patients

Pulmonary Circulation
PulmonaryRespiratory Medicine
2020English

Heparin Does Not Modify Plasma Daunomycin Disappearance in Acute Leukaemia Patients

British Journal of Cancer
Cancer ResearchOncology
1980English

Hormone Therapy Does Not Modify Emotion-Induced Brain Activity in Older Women

Hormones and Behavior
EndocrineEndocrinologyBehavioral NeuroscienceAutonomic Systems
2009English

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2017English

Bronchodilator Tolerance and Rebound Bronchoconstriction During Regular Inhaled Β -Agonist Treatment

Respiratory Medicine
PulmonaryRespiratory Medicine
2000English

GSTP1 Does Not Modify Mc1r Effects on Melanoma Risk

Experimental Dermatology
BiochemistryDermatologyMolecular Biology
2017English

Withdrawal of Inhaled Corticosteroids in COPD Patients: Rationale and Algorithms

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2019English

Inhaled Short Acting Beta Agonist Use in COPD and the Risk of Acute Myocardial Infarction

Thorax
PulmonaryRespiratory Medicine
2003English

Tomato-Rich (Mediterranean) Diet Does Not Modify Inflammatory Markers

Clinical and Investigative Medicine
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy